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Purpose or Objective
To analyze the tolerance in the French randomized phase 3 trial (BONBIS) that investigated the role of the boost to the tumor bed after breast-conserving surgery for ductal carcinoma in situ (DCIS).
Material and Methods
From November 2008 to July 2014, 2004 DCIS patients were treated by tumorectomy followed by whole-breast irradiation (WBI) to a dose of 50 Gy in 25 fractions for 5 weeks. Patients were randomized after surgery and before WBI between an additional boost to the primary tumor bed (16 Gy in 8 fractions of 2 Gy, n=1002) and no further treatment (n=1002). Stratification factors were centre, age (below or above40), hormonotherapy (yes or no), histological grade (low or intermediate or high), diagnosis mode (clinically or by mammography), surgical margins (1-2 mm vs 3 mm). Acute toxicities were prospectively recorded from baseline to 3 months after radiotherapy completion. Results A total of 1928 DCIS patients were evaluable for acute tolerance. Median age was 57 years. Re-excision was needed in 20% of patients in each treatment arm, mainly due to involved margins orpostoperative complications. Median time for radiotherapy initiation was 54 days from surgery [min; max=5; 146] . Mean volumes of breast (CTV1) and of boost (CTV2) were 545 cc [min; max= 6; 2818] and 25 cc [min; max= 0; 754], respectively. A significant higher rate of radiotherapy disruption was observed in boost arm (3.9% vs 1.5%; p=0.015) due to acute toxicities occurrence with a mean time of disruption of 3 days. A significantly higher rate of grade ≥2 overall toxicities (including skin, edema, pain) was observed in the boost arm (54.6% vs 36.4%; p<0.001). Similarly, grade 3 erythema was significantly increased in the boost arm (5.4% vs 2.1%; p<0.001).
Conclusion
In the boost arm, a higher rate of grade ≥2 acute toxicities was observed compared to the control arm. However, grade 3 erythema was quite low even though its occurrence was significantly higher in the boost arm. A multivariate analysis of acute toxicities will be presented at the congress. 
Seroma prevalence in this study was lower than previously reported, perhaps reflecting the proportion of patients receiving chemotherapy in whom seroma resolves. Seroma was not associated with patient-reported breast appearance change but haematoma was a significant risk factor. Smoking cessation pre-radiotherapy should be encouraged to reduce AE.
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Purpose or Objective
Recent studies have demonstrated a dose-effect relationship between radiation dose to the heart and the risk of an acute coronary event (ACE). However, knowledge on the exact underlying mechanisms behind this radiation-induced cardiac toxicity is lacking. Such information is crucial for the development of new strategies to optimize radiotherapy (RT) treatment planning. We hypothesized that radiation dose to atherosclerotic plaques leads to subsequent inflammatory reactions and increased risk of ACEs. Thus, dose to the plaques may be a stronger predictor of an ACE after RT than the dose to the left anterior descending coronary artery (LAD). Therefore, the aim of this study was to investigate the association between radiation dose to the LAD and the LAD-plaques and the risk of an ACE in breast cancer (BC) patients treated with 3D conformal radiation therapy.
Material and Methods
The study cohort consisted of 952 BC patients treated with postoperative RT after breast conserving surgery. The LAD was delineated using an auto-segmentation tool. After calculation of the coronary artery calcium score, LADplaques with Hounsfield units ≥130 were manually delineated. The primary endpoint was the cumulative incidence of an ACE (defined according to Darby et al.) 9 years after treatment. For each individual patient, the mean heart dose (MHD), mean dose to the LAD and the mean dose to the LAD-plaques were collected from planning CT scans. First, the relation between the dose to the LAD and the LAD-plaques and ACEs was analyzed with an univariable Cox-regression analysis. Then, an association analysis using a Cox-regression model was performed, only including patients who had a LAD-plaque. Furthermore, we used a multivariable Cox-regression analysis to calculate the excess risk of an ACE per patient including age, cardiac risk factors (0 or ≥1) and mean dose to the heart and LAD-plaques.
Results
The median follow-up time was 7.5 years (range: 0.1-10.1 years). In total, 31 patients developed an ACE during follow-up. 167 patients (17.5%) had a LAD-plaque. Univariable Cox-regression analysis showed that the impact of the dose to the LAD-plaque was much stronger than the impact of the MHD and the mean dose to the LAD (Figure 1) . A significant but modest association between radiation dose to the LAD and ACEs was found (regression coefficient 0.053 (95% CI 1.014-1.096), P=0.008). However, a much stronger and significant association was found between the mean dose to the LAD-plaques and ACEs (regression coefficient 0.323 (95% CI 1.129-1.689), P=0.002). In figure 2 , the NTCP-curves are shown for a 50-year old patient in the presence of a cardiac risk factor for ACE.
Conclusion
The results of this study suggest that mean dose to the atherosclerotic plaque in the LAD is more important for the development of an ACE in BC patients than the MHD, possibly due to radiation-induced inflammatory reactions in pre-existent plaques. This will be further investigated.
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